Notice Number: NOT-NS-20-056
Key Dates
Release Date: April 28, 2020
PAR-18-543
Issued by
National Institute of Neurological Disorders and Stroke (NINDS)
Purpose
The purpose of this Notice is to inform interested applicants that the expiration date for the Funding Opportunity Announcement (FOA) PAR-18-543 "CREATE Bio Development Track: Nonclinical and Early-Phase Clinical Development for Biologics (U44 Clinical Trial Optional)" will be extended. An additional non-AIDS application due date of February 12, 2021 and AIDS and AIDS-related applications due date of May 7, 2021 has been added for this FOA. This FOA expires on May 8, 2021. Changes are shown in bold italics below.
The Key Dates table is updated accordingly:
Part 1. Overview Information
Key Dates
Application Due Date(s) |
February 20, 2018, July 18, 2018, February 13, 2019, July 18, 2019, February 13, 2020, and July 20, 2020), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| AIDS Application Due Date(s) | May 7, 2018; September 7, 2018; May 7, 2019; September 7, 2019; May 7, 2020; and September 7, 2020, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| Scientific Merit Review | June 2018; November 2018; June 2019; November 2019; June 2020; November 2020 |
| Advisory Council Review | October 2018; January 2019; October 2019; January 2020; October 2020; January 2021 |
| Earliest Start Date | December 2018 |
| Expiration Date | September 8, 2020 |
Modified to Read:
Application Due Date(s) |
February 20, 2018, July 18, 2018, February 13, 2019, July 18, 2019, February 13, 2020, July 20, 2020), and February 12, 2021 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| AIDS Application Due Date(s) | May 7, 2018; September 7, 2018; May 7, 2019; September 7, 2019; May 7, 2020; and September 7, 2020, May 7, 2021 by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| Scientific Merit Review | June 2018; November 2018; June 2019; November 2019; June 2020; November 2020, June 2021 |
| Advisory Council Review | October 2018; January 2019; October 2019; January 2020; October 2020; January 2021, October 2021 |
| Earliest Start Date | December 2018 |
| Expiration Date | May 8, 2021 |
All other aspects of this FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Chris Boshoff, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email: [email protected]
and Human Services (HHS)
